FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francesco Gentili

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Radioligand Assay

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Francesco Gentili; Claudia Cardinaletti; Cristian Vesprini; Francesca Ghelfi; Aniket Farande; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Laura Mattioli; Marina Perfumi; Alan Hudson; Maria Pigini
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions.
Francesco Gentili; Claudia Cardinaletti; Cristian Vesprini; Antonio Carrieri; Francesca Ghelfi; Aniket Farande; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Jonne M Laurila; Anna Huhtinen; Mika Scheinin; Maria Pigini
Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior.
Pierre-Antoine Crassous; Claudia Cardinaletti; Antonio Carrieri; Bruno Bruni; Massimo Di Vaira; Francesco Gentili; Francesca Ghelfi; Mario Giannella; Hervé Paris; Alessandro Piergentili; Wilma Quaglia; Stéphane Schaak; Cristian Vesprini; Maria Pigini
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francesco Gentili (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Francesco Gentili; Claudia Cardinaletti; Cristian Vesprini; Francesca Ghelfi; Aniket Farande; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Laura Mattioli; Marina Perfumi; Alan Hudson; Maria Pigini
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions.
Journal of medicinal chemistry 2008;51(16):5130-4.
2008: Francesco Gentili; Claudia Cardinaletti; Cristian Vesprini; Antonio Carrieri; Francesca Ghelfi; Aniket Farande; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Jonne M Laurila; Anna Huhtinen; Mika Scheinin; Maria Pigini
Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior.
Journal of medicinal chemistry 2008;51(14):4289-99.
2007: Pierre-Antoine Crassous; Claudia Cardinaletti; Antonio Carrieri; Bruno Bruni; Massimo Di Vaira; Francesco Gentili; Francesca Ghelfi; Mario Giannella; Hervé Paris; Alessandro Piergentili; Wilma Quaglia; Stéphane Schaak; Cristian Vesprini; Maria Pigini
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist.
Journal of medicinal chemistry 2007;50(16):3964-8.
2007: Francesco Gentili; Maria Pigini; Alessandro Piergentili; Mario Giannella
Agonists and antagonists targeting the different alpha2-adrenoceptor subtypes.
Current topics in medicinal chemistry 2007;7(2):163-86.
2006: Francesco Gentili; Claudia Cardinaletti; Antonio Carrieri; Francesca Ghelfi; Laura Mattioli; Marina Perfumi; Cristian Vesprini; Maria Pigini
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.
European journal of pharmacology 2006;553(1-3):73-81.
2006: Francesco Gentili; Nathalie Pizzinat; Catherine Ordener; Sophie Marchal-Victorion; Agnès Maurel; Robert Hofmann; Pierre Renard; Philippe Delagrange; Maria Pigini; angelo parini; Mario Giannella
3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor.
Journal of medicinal chemistry 2006;49(18):5578-86.
2005: Wilma Quaglia; Giorgio Santoni; Maria Pigini; Alessandro Piergentili; Francesco Gentili; Michela Buccioni; Michela Mosca; Roberta Lucciarini; Consuelo Amantini; Massimo Ivan Nabissi; Patrizia Ballarini; Elena Poggesi; Amedeo Leonardi; Mario Giannella
Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.
Journal of medicinal chemistry 2005;48(24):7750-63.
2004: Francesco Gentili; Francesca Ghelfi; Mario Giannella; Alessandro Piergentili; Maria Pigini; Wilma Quaglia; Cristian Vesprini; Pierre-Antoine Crassous; Hervé Paris; Antonio Carrieri
alpha 2-adrenoreceptors profile modulation. 2. Biphenyline analogues as tools for selective activation of the alpha 2C-subtype.
Journal of medicinal chemistry 2004;47(25):6160-73.
2003: Alessandro Piergentili; Francesco Gentili; Francesca Ghelfi; Gabriella Marucci; Maria Pigini; Wilma Quaglia; Mario Giannella
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine.
Bioorganic & medicinal chemistry 2003;11(18):3901-11.
2003: Francesco Gentili; Pascal Bousquet; Livio Brasili; Monique Dontenwill; Josiane Feldman; Francesca Ghelfi; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Maria Pigini
Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues.
Journal of medicinal chemistry 2003;46(11):2169-76.
2002: Wilma Quaglia; Maria Pigini; Alessandro Piergentili; Mario Giannella; Francesco Gentili; Gabriella Marucci; Antonio Carrieri; Angelo Carotti; Elena Poggesi; Amedeo Leonardi; Carlo Melchiorre
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
Journal of medicinal chemistry 2002;45(8):1633-43.
2002: Francesco Gentili; Pascal Bousquet; Livio Brasili; Mariangela Caretto; Antonio Carrieri; Monique Dontenwill; Mario Giannella; Gabriella Marucci; Marina Perfumi; Alessandro Piergentili; Wilma Quaglia; Carla Rascente; Maria Pigini
Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole.
Journal of medicinal chemistry 2002;45(1):32-40.
2000: Maria Pigini; Wilma Quaglia; Francesco Gentili; Gabriella Marucci; Franco Cantalamessa; Silvia Franchini; Claudia Sorbi; Livio Brasili
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline.
Bioorganic & medicinal chemistry 2000;8(5):883-8.
2000: Carlo Polidori; Francesco Gentili; Maria Pigini; Wilma Quaglia; I Panocka; Maurizio Massi
Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites.
European journal of pharmacology 2000;392(1-2):41-9.
1999: Wilma Quaglia; Pascal Bousquet; Maria Pigini; Angelo Carotti; Antonio Carrieri; Monique Dontenwill; Francesco Gentili; Mario Giannella; F Maranca; Alessandro Piergentili; Livio Brasili
2-(2-Phenylcyclopropyl)imidazolines: reversed enantioselective interaction at I(1) and I(2) imidazoline receptors.
Journal of medicinal chemistry 1999;42(15):2737-40.
1999: Maria Pigini; Pascal Bousquet; Livio Brasili; Antonio Carrieri; Monique Dontenwill; Francesco Gentili; Mario Giannella; F Leonetti; Alessandro Piergentili; Wilma Quaglia; Angelo Carotti
Binding of tracizolines to the imidazoline receptor. Role of lipophilicity in quantitative structure-activity relationship models.
Annals of the New York Academy of Sciences 1999;881():118-22.
1998: Maria Pigini; Pascal Bousquet; Livio Brasili; Antonio Carrieri; R Cavagna; Monique Dontenwill; Francesco Gentili; Mario Giannella; F Leonetti; Alessandro Piergentili; Wilma Quaglia; Angelo Carotti
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models.
Bioorganic & medicinal chemistry 1998;6(12):2245-60.